Prognostic factors for acute graft-versus-host disease after donor lymphocyte infusions.


In a recent report of the fatal course of a rituximab-treated patient, we have demonstrated that tumor cell agglutination (TCA) might be a key mechanism of rituximab-induced adverse reactions. The pattern of intravascular leukostasis shown by histopathologic examinations was clearly different from findings in other patients with high leukocyte counts.1 Dr… (More)


1 Figure or Table

Slides referencing similar topics